生物医药ETF：11月11日融资净买入232.9万元，连续3日累计净买入567.3万元

Core Insights - The biopharmaceutical ETF (512290) experienced a net financing purchase of 2.329 million yuan on November 11, 2025, with a financing balance of 133 million yuan, indicating a positive investor sentiment towards the sector [1][3]. Financing Activity Summary - On November 11, 2025, the financing buy amounted to 9.6829 million yuan, while financing repayment was 7.3539 million yuan, resulting in a net financing purchase of 2.329 million yuan [1]. - The financing balance increased to 133 million yuan, marking a 1.78% rise compared to the previous day [3][4]. - Over the past three trading days, the cumulative net financing purchase reached 5.673 million yuan, with 13 out of the last 20 trading days showing net financing purchases [1][2]. Financing Balance Trends - The financing balance on November 10, 2025, was 130 million yuan, reflecting a net increase of 3.3329 million yuan, or 2.62% [4]. - The financing balance on November 7, 2025, was 127 million yuan, with a minimal change of 0.0112 million yuan [4]. - The financing balance on November 6, 2025, was also 127 million yuan, showing a decrease of 0.4898 million yuan, or -0.38% [4].